MDS and AML with Trisomy 8 as the Sole Chromosome Aberration Show Different Sex Ratios and Prognostic Profiles: A Study of 115 Published Cases

American Journal of Hematology

Volumn 56, Issue 4, 1997, Pages 224-229

  Pedersen, Bent ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

AML; Chromosome 8; MDS; Prognosis; Sex ratio; Trisomy

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME 8; CHROMOSOME ABERRATION; FEMALE; GENETICS; HUMAN; INFANT; MALE; MIDDLE AGED; MORTALITY; MYELODYSPLASTIC SYNDROME; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL; TRISOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RETROSPECTIVE STUDIES; SEX RATIO; SURVIVAL ANALYSIS; TRISOMY;

EID: 0031449768     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199712)56:4<224::AID-AJH5>3.0.CO;2-Z     Document Type: Article

References (54)

1. Heim S, Mitelman F: "Cancer Cytogenetics." New York, Alan R. Liss Inc., 1995.
2. Pedersen B, Jensen IM: Trisomy 13: A preferentially male chromosome aberration interfering specifically with myeloid proliferation and differentiation? Cancer Genet Cytogenet 57:79, 1991.
3. Pedersen B, Ellegaard J: A factor encoded by 7q31 suppresses expansion of the 7q-clone and delays cytogenetic progression. Cancer Genet Cytogenet 78:181, 1994.
4. Billström R, Thiede T, Hansen S, Heim S, Kristoffersson U, Mandahl N, Mitelman F: Bone marrow karyotype and prognosis in primary myelodysplastic syndromes. Eur J Hematol 41:341, 1988.
5. Pedersen B: Survival of patients with t(1;7)(p11;p11). Report of two cases and review of the literature. Cancer Genet Cytogenet 60:53, 1992.
6. Pedersen B: Anatomy of the 5q-deletion. Different sex ratios and deleted 5q bands in MDS and AML. Leukemia 10:1883, 1996.
7. Hoyle CF, Bastos Md, Wheatley K, Sherrington D, Fischer PJ, Rees JKH, Gray R, Hayhoe FGH: AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: Results from the MRC's 9th AML trial. Br J Haematol 72:45, 1989.
8. Alimena G, Gastaldi R, De Cuia MR, Gallo E, Dallapiccola B: 5q-chromosome in a case of acute nonlymphocytic leukemia (ANLL): The marker of a polyphasic disease? Haematologica 67:261, 1982.
9. Mitelman F, Brandt L, Nilsson PG: Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 6:1229, 1978.
10. Testa JR, Mintz U, Rowley JD, Vardiman JW, Golomb HM: Evolution of karyotypes in acute nonlymphocytic leukemia. Cancer Res 39:3619, 1979.
11. Panani A, Papayannis AG, Sioula E: Chromosome aberrations and prognosis in preleukemia. Scand J Haematol 24:97, 1980.
12. Borgström GH, Teerenhovi L, Vuopio P, Andersson LC, Knuutila S, Elonen E, Chapelle Ad: Chromosome studies in acute lymphoblastic leukaemia (ALL). Scand J Haematol 26:241, 1981.
13. Hagemeijer A, Hählen K, Abels J: Cytogenetic follow-up of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia. Cancer Genet Cytogenet 3:109, 1981.
14. Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccola B: Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 4:197, 1981.
15. Yunis JJ, Bloomfield CD, Ensrud K: All patients with acute nonlymphocytic leukemia may have a chromosomal defect. New Engl J Med 305:135, 1981.
16. Bernstein R, Pinto MR, Morcom G, Macdougall LG, Bezwoda W, Dukes I, Penfold G, Mendelow B: Karyotype analysts in acute nonlymphocytic leukemia (ANLL): Comparison with ethnic group, age, morphology, and survival. Cancer Genet Cytogenet 6:187, 1982.
17. Larson RA, Le Beau MM, Vardiman JW, Testa JR, Golomb HM, Rowley JD: The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: A 12-year study (1970-1982). Cancer Genet Cytogenet 10:219, 1983.
18. Li YS, Khalid G, Hayhoe FG: Correlation between chromosomal pattern, cytological subtypes, response to therapy, and survival in acute myeloid leukaemia. Scand J Haematol 30:265, 1983.
19. Bernard P, Reiffers J, Lacombe F, Dachary D, Boisseau R, Broustet A: A stage classification for prognosis in adult acute myelogenous leukaemia based upon patients' age, bone marrow karyotype and clinical features. Scand J Haematol 32:429, 1984.
20. Hörnsten P, Lindquist R, Gahrton G: Prognostic implications of in vitro colony studies and clonal chromsomal aberrations in adults with acute leukaemia. Scand J Haematol 32:297, 1984.
21. Ohyashiki K: Nonrandom cytogenetic changes in human acute leukemia and their clinical implications. Cancer Genet Cytogenet 11:453, 1984.
22. Yunis JJ, Brunning RD, Howe RB, Lobell M: High-resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia. New Engl J Med 311:812, 1984.
23. Goetz P, Stary J, Petrakova A, Hrodek O, Dundekova B, Venclikova K, Zavadova H: Cytogenetic and clinical data of acute lymphoblastic leukemia in children. Clin Genet 24:312, 1985.
24. Testa JR, Misawa S, Oguma N, Sloten Kv, Wiernik PH: Chromosomal alterations in acute leukemia patients studied with improved culture methods. Cancer Res 45:430, 1985.
25. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD: Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 67:1765, 1986.
26. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 4:325, 1986.
27. Misawa S, Hogge DE, Oguma N, Wiernik PH, Testa JR: Detection of clonal karyotypic abnormalities in most patients with acute nonlymphocytic leukemia examined using short-term culture techniques. Cancer Genet Cytogenet 22:239, 1986.
28. Yunis JJ, Rydell RE, Oken MM, Arnesen MA, Mayer MG, Lobell M: Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 67:1721, 1986.
29. Pui CH, Raimondi SC, Murphy SB, Ribeiro RC, Kalwinsky DK, Dahl GV, Crist WM, Williams DL: An analysis of leukemic cell chromosomal features in infants. Blood 69:1289, 1987.
30. Rege-Cambrin G, Mecucci C, Tricot G, Louwagie A, Van Hove W, Francart H, Van Den Berghe H: A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet 25:233, 1987.
31. Horiike S, Taniwaki M, Misawa S, Abe T: Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 62:1129, 1988.
32. Michael PM, Carson OM, Ekert H, Tauro G, Rennie GC, Pilkington GR: Prospective study of childhood acute lymphocytic leukemia: Hematologic, immunologic, and cytogenetic correlations. Med Pediatr Oncol 16:153, 1988.
33. Misawa S, Yashige H, Horiike S, Taniwaki M, Nishigaki H, Okuda T, Yokota S, Tsuda S, Edagawa J, Imanishi H, Takino T, Inazawa J, Abe T, Nakanishi S, Nakagawa M, Kobayashi H, Maekawa T, Fujii H, Akaogi T, Hayashi H, Fujiyama Y, Kohsaki M: Detection of karyotypic abnormalities in most patients with acute nonlymphocytic leukemia by adding ethidium bromide to short-term cultures. Leuk Res 12:719, 1988.
34. Prigogina EL, Puchkova GP, Mayakova SA: Nonrandom chromosomal abnormalities in acute lymphoblastic leukemia of childhood. Cancer Genet Cytogenet 32:183, 1988.
35. Iurlo A, Mecucci C, Van Orshoven A, Michaux J-L, Boogaerts M, Noens L, Bosly A, Louwagie A, Van Den Berghe H: Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome. Cancer Genet Cytogenet 43:227, 1989.
36. Garipidou V, Yamada T, Prentice HG, Seeker Walker LM: Trisomy 8 in acute lymphoblastic leukemia (ALL): A case report and update of the literature. Leukemia 4:717, 1990.
37. Jotterand-Bellomo M, Parlier V, Schmidt PM, Beris P: Cytogenetic analysis of 54 cases of myelodysplastic syndrome. Cancer Genet Cytogenet 46:157, 1990.
38. Kobayashi H, Kaneko Y, Maseki N, Sakurai M: Karyotypically unrelated clones in acute leukemias and myelodysplastic syndromes. Cancer Genet Cytogenet 47:171, 1990.
39. Suciu S, Kruse R, Weh HJ, Hossfeld DK: Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genet Cytogenet 44:15, 1990.
40. Iwabuchi A, Ohyashiki K, Ohyashiki JH, Sasao I, Murakami T, Kodama A, Toyama K: Trisomy of chromosome 8 in myelodysplastic syndrome. Significance of the fluctuating trisomy 8 population. Cancer Genet Cytogenet 62:70, 1992.
41. Manso AIG, Marcilla AG, Barreiro E, Gilsanz F: Cytohematologic and cytogenetic prognostic factors at diagnosis and in the evolution of 46 primary myelodysplastic syndromes. Cancer Genet Cytogenet 61:174, 1992.
42. Olufunmilayo I, Olopade MT, Thangavelu M, Larson RA, Mick R, Kowal-Vern A, Schumacher HR, Le Beau MM, Vardiman JW, Rowley JD: Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood 80:2873, 1992.
43. Sole F, Prieto F, Badia L, Woessner S, Florensa L, Caballin MR, Coll MD, Besses C, Sans Sabrafen J: Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet Cytogenet 64:12, 1992.
44. Dan K, An E, Futaki M, Inokuchi K, Gomi S, Yamada T, Ogata K, Tanabe Y, Ohki I, Shinohara T, Nomura T: Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Acta Haematol 89:113, 1993.
45. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K: Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 54:3557, 1994.
46. Parlier V, Vanmelle G, Beris P, Schmidt P, Tobler A, Haller E, Bellomo MJ: Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome: Prognostic significance of morphology and chromosome findings. Cancer Genet Cytogenet 78:219, 1994.
47. Swansbury GJ, Lawler SD, Alimena G, Arthur D, Berger R, Van Den Berghe H, Bloomfield CD, de la Chappelle A, Dewald G, Garson OM, Hagemeijer A, Mitelman F, Rowley JD, Sakurai M: Long-term survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenet 73:1, 1994.
48. Tien HF, Wang CH, Chuang SM, Lee FY, Liu MC, Chen YC, Shen MC, Lin KH, Lin DS: Acute leukemic transformation of myelodysplastic syndrome: Immunophenotypic, genotypic, and cytogenetic studies. Leuk Res 19:595, 1995.
49. Mühlematter D, Castagné C, Bruzzese O, Clément F, Schmidt PM, Jotterand-Bellomo M: Tetrasomy 8 in a patent with acute nonlymphocytic leukemia: A metaphase and interphase study with fluorescence in situ hybridization. Cancer Genet Cytogenet 89:44, 1996.
50. Weh HJ, Seeger D, Junge I, Hossfeld DK: Trisomy 8 preceding diagnosis of acute nonlymphocytic leukemia by 2 years in a patient with multiple myeloma without cytological evidence of myelodysplasia. Ann Hematol 72:81, 1996.
51. Sachs L: "Applied Statistics. A Handbook of Techniques." New York: Springer-Verlag, 1978.
52. Mitelman F: "Catalog of Chromosome Aberrations in Cancer." New York: Wiley-Liss, 1994.
53. Beutler E, Lichtman MA, Coller BS, Kipps TJ: "Williams Hematology." New York: McGraw-Hill Inc. 1995, p. 261, 263.
54. Pedersen B: Trisomy 4: Clinical picture, hematology, and survival. Presentation of two cases and review of the literature. Hematol Pathol 6:161, 1992.